Hongxia Ma
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 1%
- Hepatitis Viruses Studies and Epidemiology
Papers in
-
- RNA modifications and cancer 54
- Epigenetics and DNA Methylation 27
- DNA Repair Mechanisms 16
- Cancer-related gene regulation 16
-
- Cancer-related molecular mechanisms research 44
- MicroRNA in disease regulation 25
- Co-authors
- Zhibin Hu (154 shared papers)Hongbing Shen (154 shared papers)Guangfu Jin (126 shared papers)Qingyi Wei (32 shared papers)Juncheng Dai (90 shared papers)Jiaping Chen (25 shared papers)Yijiang Chen (8 shared papers)Meng Zhu (60 shared papers)
- Journals
- PLoS ONE (14 papers)Molecular Carcinogenesis (14 papers)International Journal of Cancer (10 papers)Gene (9 papers)Carcinogenesis (8 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Hongxia Ma
260 papers receiving 7.0k citations
Hongxia Ma's Hit Papers
Peers
Comparison fields: 5 of 152
- Cancer Research 2.1k
- Hepatology 469
- Infectious Diseases 1.1k
- Modeling and Simulation 204
- Molecular Biology 2.8k
Countries citing papers authored by Hongxia Ma
This map shows the geographic impact of Hongxia Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxia Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxia Ma more than expected).
Fields of papers citing papers by Hongxia Ma
This network shows the impact of papers produced by Hongxia Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxia Ma. The network helps show where Hongxia Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Hongxia Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 269 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China Hit paper breakdown → | 2020 | 887 |
| 2 | Genetic variants of miRNA sequences and non–small cell lung cancer survival Hit paper breakdown → | 2008 | 511 |
| 3 | 2009 | 272 | |
| 4 | 2009 | 255 | |
| 5 | 2021 | 227 | |
| 6 | 2005 | 190 | |
| 7 | 2012 | 182 | |
| 8 | 2018 | 172 | |
| 9 | 2009 | 114 | |
| 10 | 2017 | 93 | |
| 11 | 2010 | 86 | |
| 12 | 2005 | 69 | |
| 13 | 2021 | 68 | |
| 14 | 2005 | 61 | |
| 15 | 2011 | 60 | |
| 16 | 2012 | 57 | |
| 17 | 2014 | 54 | |
| 18 | 2022 | 52 | |
| 19 | 2015 | 51 | |
| 20 | 2016 | 49 |
About Hongxia Ma
Hongxia Ma is a scholar working on Molecular Biology, Cancer Research, Genetics, Epidemiology and Oncology, having authored 269 papers that have together received 7.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (54 papers), Cancer-related molecular mechanisms research (44 papers), Epigenetics and DNA Methylation (27 papers), MicroRNA in disease regulation (25 papers), Genetic Associations and Epidemiology (19 papers), DNA Repair Mechanisms (16 papers), Cancer-related gene regulation (16 papers) and BRCA gene mutations in cancer (12 papers). The work is most often cited by research in Cancer Research (2.1k citations), Hepatology (469 citations), Infectious Diseases (1.1k citations), Modeling and Simulation (204 citations) and Molecular Biology (2.8k citations). Hongxia Ma has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhibin Hu, Hongbing Shen, Guangfu Jin, Qingyi Wei, Juncheng Dai, Jiaping Chen, Yijiang Chen, Meng Zhu, Ruifen Miao and Ci Song. Their work appears in journals such as PLoS ONE, Molecular Carcinogenesis, International Journal of Cancer, Gene and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.